PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy.
Armstrong CW, Maxwell PJ, Ong CW, Redmond KM, McCann C, Neisen J, Ward GA, Chessari G, Johnson C, Crawford NT, LaBonte MJ, Prise KM, Robson T, Salto-Tellez M, Longley DB, Waugh DJ.
Armstrong CW, et al. Among authors: ward ga.
Oncotarget. 2016 Feb 16;7(7):7885-98. doi: 10.18632/oncotarget.6955.
Oncotarget. 2016.
PMID: 26799286
Free PMC article.